en

PRODUCT DETAIL

Alhemo 15 mg/1,5 ml injekčný roztok v naplnenom pere

Code 8776E
MA number EU/1/24/1881/002
Product Form: sol inj 5 (5x1)x1,5 ml/15 mg (pero napl. - multibal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Novo Nordisk A/S, Denmark
Therapeutic Class: 87 - VARIA I
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B LOCAL HEMOSTATICS, COMBINATIONS
B02BX Other systemic hemostatics
B02BX10 Concizumab
Shelf life: 36
Container: pre-filled pen
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 13.12.2024
Validity: 13.12.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 23.01.2025
eu-flag.png sk-flag.png